Engineering the proteolytic specificity of activated protein C improves its pharmacological properties
David T. Berg(Eli Lilly (United States)), Bryan E. Jones(Richard L. Roudebush VA Medical Center), Ken Mace(Eli Lilly (United States)), Tommy Smith(Eli Lilly (United States)), Bruce Gerlitz(Eli Lilly (United States)), Ken D. Kurz(Eli Lilly (United States)), Paula F. Santa(Eli Lilly (United States)), Brian W. Grinnell(Eli Lilly (United States)), Mark A. Richardson(Eli Lilly (United States))
Cited by 58
Related Papers
The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling
|Cell|1997|1.3k
Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis
|Journal of Biological Chemistry|2001|652
An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis
|Science Translational Medicine|2013|509